|
PFDN5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.06640277006431E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.08040037921842E-10 |
| Normal-vs-Stage2 |
1.650320E-02 |
| Normal-vs-Stage3 |
3.520700E-03 |
| Normal-vs-Stage4 |
5.900600E-03 |
| Stage1-vs-Stage2 |
7.333400E-01 |
| Stage1-vs-Stage3 |
5.595800E-01 |
| Stage1-vs-Stage4 |
6.117800E-02 |
| Stage2-vs-Stage3 |
9.065800E-01 |
| Stage2-vs-Stage4 |
1.519040E-01 |
| Stage3-vs-Stage4 |
8.419600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.73600056341661E-11 |
| Normal-vs-AfricanAmerican |
8.09869999951474E-08 |
| Normal-vs-Asian |
3.994400E-04 |
| Caucasian-vs-AfricanAmerican |
4.265800E-01 |
| Caucasian-vs-Asian |
8.664800E-01 |
| AfricanAmerican-vs-Asian |
9.143200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89559479224499E-11 |
| Normal-vs-Female |
3.26380000004178E-06 |
| Male-vs-Female |
2.805200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.5291400000006E-05 |
| Normal-vs-Extreme_Weight |
2.05280015208587E-10 |
| Normal-vs-Obese |
6.64770000047277E-07 |
| Normal-vs-Extreme_Obese |
1.049990E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.310800E-01 |
| Normal_Weight-vs-Obese |
6.477800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.050360E-01 |
| Extreme_Weight-vs-Obese |
3.417600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.370000E-02 |
| Obese-vs-Extreme_Obese |
1.354370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.178100E-03 |
| Normal-vs-Age(41-60Yrs) |
8.35839952806339E-10 |
| Normal-vs-Age(61-80Yrs) |
8.88920048680575E-10 |
| Normal-vs-Age(81-100Yrs) |
4.684100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.593800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.662600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.577200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.997600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.527600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.322600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.56381590904675E-13 |
| Normal-VS-Type2 PRCC |
8.3247000000064E-05 |
| Normal-VS-KIRP CIMP |
2.426800E-01 |
| Normal-VS-Unclassified PRCC |
6.779300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.403600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.993900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.024200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.023900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.399600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.028200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.99650999999079E-05 |
| Normal-vs-N1 |
4.39220000000295E-05 |
| Normal-vs-N2 |
8.126200E-02 |
| N0-vs-N1 |
7.741800E-01 |
| N0-vs-N2 |
3.462200E-02 |
| N1-vs-N2 |
1.974550E-01 |
|
|
